Fluent Stream Corp
Purchase-Price Allocation
Intangibles
$28.0M
Pro-Forma Combined Entity
Revenue
$294.0M
OOMA, INC. — Key Metrics
3 years of history · ending 2026-01-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$0
Book Value Per Share
$3
Free Cash Flow Per Share
$1
Cash Per Share
$1
Revenue Per Share
$10
OCF Per Share
$1
Return on Equity
7.2%
Return on Assets
3.4%
Return on Invested Capital
3.7%
Debt to Equity
0.55
Current Ratio
0.93
Quick Ratio
0.70
Asset Turnover
1.45
Days Sales Outstanding
15.79
Days Payables Outstanding
28.40
Days Inventory On Hand
55.50
Cash Conversion Cycle
42.89
R&D / Revenue
18.4%
SBC / Revenue
5.5%
Capex / Revenue
2.0%
Working Capital
$-5M
Net Current Asset Value
$-68M
Invested Capital
$144M
OCF / Net Income
4.29
FCF / Net Income
3.42
Accruals Ratio (Sloan)
-9.3%
Net Debt
$38M
Net Debt / EBITDA
4.36
Interest Coverage
—
Cash Coverage
—
Capex Coverage
4.95
Tangible Common Equity
$-19M
TCE / Total Assets
-8.5%
Goodwill / Total Assets
21.9%
NOPAT
$4M
Cash ROIC
19.2%
WC / Revenue
-1.8%
Capex / D&A
1.27
Reinvestment Rate
28.0%
Total Payout Ratio
180.0%
Asset Growth vs Revenue Growth
46.0%
Revenue 5Y CAGR
10.1%
FCF 5Y CAGR
78.9%
EBITDA 5Y CAGR
133.4%
Book Value 5Y CAGR
18.6%
Stock Price (FY-end)
$12
Market Cap
$330M
P/E Ratio
51.15
P/S Ratio
1.21
P/B Ratio
3.56
P/TB Ratio
9.58
P/OCF Ratio
11.93
P/FCF Ratio
14.95
Enterprise Value
$368M
EV / EBITDA
42.53
EV / Sales
1.35
EV / FCF
16.66
FCF Yield
6.7%
Shareholder Yield
-1.0%
Buyback Yield
3.5%
R&D Yield
15.2%
Capex Yield
1.7%
Graham Number
$4
Shares Variation (YoY)
5.4%
Beta (5Y)
0.82
Cost of Equity
8.6%
Cost of Debt (after tax)
—
52W High
$15
52W Low
$11
Trailing Return 1Y
-20.5%
Trailing Return 5Y
-23.1%
F-Score (Piotroski)
5.00
Z-Score (Altman)
1.89
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Stock Price on Earnings Dates
OOMA, INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | -3.00% | -3.00% | 1.00% | 4.00% | 7.00% | 2.00% |
| Foreign Rate Differential | 3.00% | 11.00% | 3.00% | 5.00% | -5.00% | — |
| Other Adjustments | — | — | — | — | — | — |
| R&D Tax Credits | 10.00% | 113.00% | -24.00% | 73.00% | 22.00% | 30.00% |
| SBC (Nondeductible) | 11.00% | 88.00% | -10.00% | -28.00% | -14.00% | 24.00% |
| Valuation Allowance Change | -8.00% | -1.69% | 29.00% | 35.00% | -44.00% | -110.00% |
| Tax Law Change | — | — | — | — | — | -21.00% |
| Effective Tax Rate | -4.00% | 0.00% | 33.00% | 69.00% | -12.00% | -48.00% |
Cash vs Accrual
| Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $85.0K | — | −$1.8M | −$2.0M | $760.0K | −$2.1M |
| Income Taxes Paid (Cash) | — | $34.0K | $409.0K | $800.0K | $600.0K | $739.0K |
OOMA, INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Phone Com
Purchase-Price Allocation
Intangibles
$18.9M
Deferred Tax Liability
$2.5M
Pro-Forma Combined Entity
Revenue
$294.4M